Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle

被引:30
|
作者
Fujimoto, J [1 ]
Ichigo, S [1 ]
Sakaguchi, H [1 ]
Hirose, R [1 ]
Tamaya, T [1 ]
机构
[1] Gifu Univ, Sch Med, Dept Obstet & Gynecol, Gifu 5008705, Japan
关键词
PD-ECGF; neovascularization; uterine endometrium;
D O I
10.1093/molehr/4.5.509
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Steroid hormones, e.g. progesterone and oestradiol, may be responsible for the production and expression of a variety of angiogenic growth factors present in endometrial tissue. The expression of platelet-derived endothelial cell growth factor (PD-ECGF) in neovascularization after regression of the microvessels in the endometrium was examined. PD-ECGF protein expression in the endometrium during the menstrual cycle was determined by a sandwich enzyme immunoassay. Transcription levels of PD-ECGF were measured by a quantitative reverse transcription-polymerase chain reaction (RT-PCR) Southern blot technique. The data show that levels of PD-ECGF protein and mRNA in uterine endometrium did not alter during the proliferative phase prior to ovulation. During the midcycle phase a sharp transient fall in mRNA revels accompanied by a gradual drop in protein levels was observed. After ovulation transcription of PD-ECGF recovered with a sharp increase in mRNA levels which persisted during the ovulatory phase. PD-ECGF protein levels were temporarily low after ovulation, but increased remarkably through the late secretory phase. PD-ECGF expression in the endometrium seems to be inversely correlated with oestradiol concentrations during the menstrual cycle.
引用
收藏
页码:509 / 513
页数:5
相关论文
共 36 条
  • [31] Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470
    Mori, J
    Haisa, M
    Naomoto, Y
    Takaoka, M
    Kimura, M
    Yamatsuji, T
    Notohara, K
    Tanaka, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (06): : 643 - 650
  • [32] A similarity model for the human angiogenic factor, thymidine phosphorylase/platelet derived-endothelial cell growth factor
    Cole, C
    Marks, DS
    Jaffar, M
    Stratford, IJ
    Douglas, KT
    Freeman, S
    ANTI-CANCER DRUG DESIGN, 1999, 14 (05): : 411 - 420
  • [33] Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor
    Kernt, M.
    Liegl, R. G.
    Rueping, J.
    Neubauer, A. S.
    Haritoglou, C.
    Lackerbauer, C. A.
    Eibl, K. H.
    Ulbig, M. W.
    Kampik, A.
    GROWTH FACTORS, 2010, 28 (03) : 211 - 220
  • [34] Frozen Fat Grafts Maintain Vascular Endothelial Growth Factor Expression and Mediate Angiogenesis During Adipose-Derived Stem Cell Enrichment for Soft Tissue Augmentation
    Lin, Chih-Hsun
    Tsai, Chi-Han
    Yang, I-Chen
    Ma, Hsu
    ANNALS OF PLASTIC SURGERY, 2022, 88 (1S) : S4 - S12
  • [35] H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle
    Sun, Ye
    Su, Li
    Wang, Zhongxiao
    Xu, Yi
    Xu, Xun
    BMC CELL BIOLOGY, 2013, 14
  • [36] H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle
    Ye Sun
    Li Su
    Zhongxiao Wang
    Yi Xu
    Xun Xu
    BMC Cell Biology, 14